A stepwise increased dose of auranofin does not influence gastrointestinal side-effects.
Johannsen
F
F
Brodin
U
U
Emmertsen
H
H
Hansen
T M
TM
Faarvang
K L
KL
Bugge
P
P
Nielsen
G L
GL
Jensen
O H
OH
Beyer
J
J
Danneskiold-Samsøe
B
B
Jarner
D
D
Arfeldt
E
E
Krohn
L
L
Nielsen
H
H
Nielsen
S E
SE
D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001310:Auranofin / Q000008:administration & dosage* / Q000009:adverse effects; D003967:Diarrhea / Q000139:chemically induced; D004311:Double-Blind Method; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D012720:Severity of Illness Index
D018501:Antirheumatic Agents; D001310:Auranofin